MERUS LABS
The Merus corporate growth strategy is driven by a product acquisition plan which employs an opportunistic approach to source product acquisition candidates. This approach allows Merus to source pharmaceutical products across broad therapeutic classes which provides access to acquisition targets not available to other players and creates a diversified strategy. Although Merus has a broad therapeutic focus, opportunities will be pursued if the application of a dedicated small scale sales force can deliver incremental product sales growth. The geographic focus will be the United States and Canada
MERUS LABS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.meruslabs.com
Total Employee:
1+
Status:
Active
Contact:
+1 416 593 3725
Total Funding:
69.73 M USD
Technology used in webpage:
SPF Microsoft Azure DNS PHP AuthSMTP NetNames DNS
Current Employees Featured
Michael Bumby Chief Financial Officer @ Merus Labs
Chief Financial Officer
Elie Farah CEO @ Merus Labs
CEO
Stock Details
Official Site Inspections
http://www.meruslabs.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Meruslabs.com lookup results from whois.corporatedomains.com server:
- Domain created: 7th-May-2009
- Domain updated: 3rd-May-2024
- Domain expires: 7th-May-2025 0 Years, 33 Days left
- Website age: 15 Years, 331 Days
- Registrar Domain ID: 1554733869_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: domainabuse@cscglobal.com
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.NETNAMES.NET
- NS2.NETNAMES.NET
- NS5.NETNAMES.NET
- NS6.NETNAMES.NET